Skip to main content

mercaptamine bitartrate (Procysbi®)

 

Appraisal in progress

Indication

Status: In progress

Treatment of proven nephropathic cystinosis. Mercaptamine reduces cystine accumulation in some cells (e.g. leukocytes, muscle and liver cells) of nephropathic cystinosis patients and, when treatment is started early, it delays the development of renal failure.

Medicine details

Medicine name mercaptamine bitartrate (Procysbi®)
Formulation 25 mg and 75 mg capsule
Reference number 4804
Indication

As above

Company Chiesi Ltd
BNF chapter Nutrition & blood
Submission type Full
Status In progress
NMG meeting date 02/03/2022
AWMSG meeting date 27/04/2022
Date of issue TBC